While disappointing from an experimental standpoint, these data are in excellent agreement with recent studies showing that CD103 marks Treg in a tumor bed [22], and once again the support the possibility that Helios-enriched, CD103+ GITR+ Treg might represent a population with a relatively enhanced suppressive capacity. Here, TNFRSF18 is linked to neoplasm.